Triple-negative breast cancer (TNBC) is defined by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2), and accounts for 20% of all invasive breast cancers (5). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.